drugset / Trial / NCT04880694
A Study to Evaluate the Safety and Effect of STC3141 Continuous Infusion in Subjects With Severe Corona Virus Disease 2019（COVID-19）Pneumonia
RandomizedParallel-groupOpen-labelTreatment
Summary
The study is a Randomized, Open-Label, Multi-Centre, Phase 2a Study to Evaluate the Safety and Effect of STC3141 Continuous Infusion in Subjects with Severe Corona Virus Disease 2019（COVID-19）Pneumonia.
Timeline
- Start
- 2021-05-20
- Primary completion
- 2022-01-07
- Completion
- 2022-01-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | STC3141 | Unknown | 58.3 mg | Other |
| Subject | STC3141 | Unknown | 87.5 mg | Other |